文献速递腹部MR

3T化学位移MRI鉴别肝细胞癌与非肝细胞癌恶性肝肿瘤

Differentiation of hepatocellular carcinoma from non-hepatocellular malignant tumours of liver by chemical-shift MRI at 3 T.
PubMed 文献 · Clin Radiol · 2019-07-09

本回顾性研究纳入47个肝细胞癌和75个非肝细胞癌恶性肝肿瘤,在3T化学位移MRI上以脾脏为参考计算脂肪百分比减影分数。以>−0.26为阈值,鉴别肝细胞癌与非肝细胞癌的敏感度95.7%、特异度89.3%、阳性预测值84.9%、阴性预测值97.1%。作者认为肝细胞癌胞质内脂质可能是有力的影像生物标志物。

要点

  • 脂肪信号百分比减影分数>−0.26提示肝细胞癌,敏感度95.7%、特异度89.3%。
  • 减影分数由肿瘤脂肪百分比减去邻近正常肝实质脂肪百分比得出。
  • 定量化学位移MRI显示的胞质内脂质可能有助于鉴别肝细胞癌与其他恶性肝肿瘤。

核心结论

  • 定量化学位移MRI显示的肝细胞癌胞质内脂质可能是鉴别肝细胞癌与其他恶性肝肿瘤的潜在有力影像生物标志物。

研究设计与样本

  • 回顾性研究,纳入2012年1月至2016年10月经3T MRI检查的47个肝细胞癌和75个非肝细胞癌恶性肝肿瘤。
  • 两名盲法观察者测量肿瘤、邻近外观正常肝实质和脾脏的信号强度,以脾脏为参考标准计算脂肪定量。
  • 减影分数为肿瘤脂肪百分比减去肝实质脂肪百分比,计算其鉴别肝细胞癌与非肝细胞癌的敏感度、特异度、阳性预测值和阴性预测值。

诊断标准与关键数值

  • 根据两名阅片者获得的最佳截断值,减影分数>−0.26考虑为肝细胞癌。
  • 47个肝细胞癌中45个减影分数≥−0.26,75个非肝细胞癌中69个减影分数<−0.26。
  • 脂肪信号百分比减影分数鉴别肝细胞癌与非肝细胞癌的敏感度95.7%、特异度89.3%、阳性预测值84.9%、阴性预测值97.1%。

临床应用与阅片要点

  • 在3T化学位移MRI上以脾脏为参考测量肿瘤与邻近肝实质脂肪百分比并计算减影分数,可辅助鉴别肝细胞癌与非肝细胞癌恶性肝肿瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To evaluate the diagnostic performance of chemical shift magnetic resonance imaging (MRI) in distinguishing hepatocellular carcinomas (HCCs) from non-hepatocellular malignant tumours (non-HCCs) of the liver.

MATERIALS AND METHODS: Patients with a diagnosis of malignant liver tumours examined at 3 T MRI were included in this retrospective study. Forty-seven HCCs and 75 non-HCCs that were studied with chemical-shift MRI between January 2012 and October 2016 were retrieved from the radiology database. Two blinded observers measured the signal intensities of the tumours, adjacent normal-looking liver parenchyma, and spleen on chemical-shift MRI. The fat quantification for HCCs, non-HCCs, and adjacent normal-looking liver parenchyma were calculated by using the spleen as a reference standard. The subtraction scores were calculated by subtracting fat percentages in liver parenchyma from those in tumours. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the fat percentage subtraction scores in distinguishing HCCs from non-HCCs were calculated.

RESULTS: According to the optimal cut-off value acquired from both readers, a subtraction score >-0.26 was considered to be a HCC. Fat signal percentage subtraction scores were ≥-0.26 in 45 of 47 HCCs and were <-0.26 in 69 of 75 non-HCCs. The sensitivity, specificity, PPV, and NPV of fat signal percentage subtraction score to differentiate HCCs from non-HCCs were found to be 95.7%, 89.3%, 84.9%, and 97.1%, respectively.

CONCLUSION: Intracytoplasmic lipid in HCCs demonstrated by quantitative chemical-shift MRI may be a potentially powerful imaging biomarker to distinguish HCCs from the other malignant liver tumours.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Ozturk K, Soylu E, Yazici Z, et al. Differentiation of hepatocellular carcinoma from non-hepatocellular malignant tumours of liver by chemical-shift MRI at 3 T. Clin Radiol. 2019. PMID: 31300210. doi:10.1016/j.crad.2019.06.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。